Characterization of the 5′-flanking region of the human dopamine transporter gene

被引:94
作者
Sacchetti, P
Brownschidle, LA
Granneman, JG
Bannon, MJ
机构
[1] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA
[3] Parke Davis Pharmaceut Res, Ann Arbor, MI 48105 USA
来源
MOLECULAR BRAIN RESEARCH | 1999年 / 74卷 / 1-2期
关键词
dopamine transporter; human; transcription regulation; cis-regulatory element; nurr1; gene;
D O I
10.1016/S0169-328X(99)00275-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The dopamine transporter (DAT) plays a major role in modulating dopamine (DA) neurotransmission by controlling the levels of this neurotransmitter in the extracellular space. We have isolated 8.3 kb of the 5'-flanking regulatory region of the human DAT (hDAT) gene and identified numerous potential elements involved in transcriptional control of the DAT. A series of hDAT-luciferase reporter constructs encompassing increasing amounts of 5'-flanking sequence was utilized in transient transfection assays assessing basal activity and response to selected stimuli. Our results suggest that the proximal hDAT 5'-flanking region displays a strong, nonselective promoter activity that is silenced through regulatory elements present in the distal portion of the 5'-flanking sequence. Although potential cyclic AMP responsive elements (CRE) were identified on the sequence, hDAT constructs were unresponsive to cyclic AMP induction. The transcription factor nurrl increases the transcriptional activity of several larger hDAT constructs, consistent with the presence of several putative NGFI-B response elements (NBRE). The cloning and functional analysis of an extensive portion of the 5'-flanking regulatory region of the hDAT gene provides further insights into the factors involved in the regulation of this gene. (C) 1999 Elsevier Science B.V, All rights reserved.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 34 条
[1]   Neurotransmitter transporters as molecular targets for addictive drugs [J].
Amara, SG ;
Sonders, MS .
DRUG AND ALCOHOL DEPENDENCE, 1998, 51 (1-2) :87-96
[2]  
BANNON MJ, 1999, IN PRESS PSYCHOPHARM
[3]   Dopamine biosynthesis is selectively abolished in substantia nigra ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene [J].
Castillo, SO ;
Baffi, JS ;
Palkovits, M ;
Goldstein, DS ;
Kopin, IJ ;
Witta, J ;
Magnuson, MA ;
Nikodem, VM .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1998, 11 (1-2) :36-46
[4]  
CHONG JA, 1990, CELL, V80, P949
[5]  
COOPER J, 1996, BIOCH BASIS NEUROPHA
[6]   ENDOCRINE AND NEUROGENIC REGULATION OF THE ORPHAN NUCLEAR RECEPTORS NUR77 AND NURR-1 IN THE ADRENAL-GLANDS [J].
DAVIS, IJ ;
LAU, LF .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) :3469-3483
[7]   HUMAN AND MOUSE DOPAMINE TRANSPORTER GENES - CONSERVATION OF 5'-FLANKING SEQUENCE ELEMENTS AND GENE STRUCTURES [J].
DONOVAN, DM ;
VANDENBERGH, DJ ;
PERRY, MP ;
BIRD, GS ;
INGERSOLL, R ;
NANTHAKUMAR, E ;
UHL, GR .
MOLECULAR BRAIN RESEARCH, 1995, 30 (02) :327-335
[8]   UNIQUE RESPONSE PATHWAYS ARE ESTABLISHED BY ALLOSTERIC INTERACTIONS AMONG NUCLEAR HORMONE RECEPTORS [J].
FORMAN, BM ;
UMESONO, K ;
CHEN, J ;
EVANS, RM .
CELL, 1995, 81 (04) :541-550
[9]  
GIROS B, 1992, MOL PHARMACOL, V42, P383
[10]   FUNCTIONAL TESTING OF HUMAN DOPAMINE-D1 AND DOPAMINE-D5 RECEPTORS EXPRESSED IN STABLE CAMP-RESPONSIVE LUCIFERASE REPORTER CELL-LINES [J].
HIMMLER, A ;
STRATOWA, C ;
CZERNILOFSKY, AP .
JOURNAL OF RECEPTOR RESEARCH, 1993, 13 (1-4) :79-94